📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Synergism of red blood cells and tranexamic acid in the inhibition of fibrinolysis. (2024)

First Author: Raska A

Attributed to: The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury. funded by GCRF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jtha.2023.11.009

PubMed Identifier: 38016517

Publication URI: http://europepmc.org/abstract/MED/38016517

Type: Journal Article/Review

Volume: 22

Parent Publication: Journal of thrombosis and haemostasis : JTH

Issue: 3

ISSN: 1538-7836